Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
paolo.marchetti@uniroma1.it
Paolo Marchetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
paolo.marchetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice
SUPPORTIVE CARE IN CANCER
2019
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
CLINICAL LUNG CANCER
2019
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach
JOURNAL OF CLINICAL ONCOLOGY
2019
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study
2019
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours
2019
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
2018
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice
ANALYTICAL CELLULAR PATHOLOGY
2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway
CANCER IMMUNOLOGY RESEARCH
2018
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma
MEDICINE
2018
Hyperprogressive disease and early hypereosinophilia after anti-PD-1 treatment. a case report
DRUG SAFETY - CASE REPORTS
2018
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival
MEDICAL ONCOLOGY
2018
The microbiota impact. bacteria shaping immunity, disease and response to therapy
TRANSLATIONAL CANCER RESEARCH
2018
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition
MOLECULAR AND CLINICAL ONCOLOGY
2018
The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one
CANCER TREATMENT REVIEWS
2018
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
JOURNAL OF TRANSLATIONAL MEDICINE
2018
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines
ONCOTARGET
2018
Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial
JOURNAL OF CLINICAL ONCOLOGY
2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
CANCER BIOLOGY & THERAPY
2018
Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme
EUROPEAN JOURNAL OF CANCER
2018
Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: a case report
MEDICINE
2018
« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma